CoSense End Tidal CO Monitor Device

A “Gold Standard” Test for Diagnosing & Quantifying Hemolysis in Neonates and Infants
Please Contact Your Local Sales Rep About Pricing & Availability

Jaundice management is complex, but improving outcomes is easier than you think with CoSense® ETCOc testing. A simple breath test provides early and accurate measurement of hemolysis and neurotoxic risk that can lead to hemolytic hyperbilirubinemia (HB) and kernicterus.

Diagnose and Quantify Hemolysis Early, Send Them Home With Confidence

• Supports Best Practices. AAP Recommends the Use of ETCOc
• 15-30 Seconds to collect a breath sample with the CoSense® ETCOc Monitor
• 100% Simple and non-Invasive
• <5 Minutes for the CoSense® ETCOc Monitor to analyze the baby’s breath sample and accurately measure hemolysis; performed  at the bedside with results in <5 minute
• 3 Easy Steps to operate and no calibration required
• 50% Decrease in blood tests on newborns for managing hyperbilirubinemia
• 20% Decrease in phototherapy and improved utilization
• $200K Savings from the 50% decrease in blood tests on newborns (University of Utah, 2021 Study)
• Decreased readmissions
• Decreased length of stay in the hospital